Muscle Oxygen Sensors Market

What is the muscle oxygen sensors market forecast to be worth by 2036?

USD 28.0 million in 2026 to USD 130.0 million by 2036, at 16.6% CAGR.

• The muscle oxygen sensors market crossed a valuation of USD 24.0 million in 2025. Demand is expected to increase from USD 28.0 million in 2026 to USD 130.0 million by 2036.
• The market is forecast to record 16.6% CAGR from 2026 to 2036 as endurance athletes and rehabilitation clinics use wearable NIRS devices for localized muscle monitoring.
• Muscle oxygen sensors use near-infrared spectroscopy to measure local muscle oxygen saturation during exercise and recovery. A 2025 Bioengineering study validated a wearable continuous-wave NIRS sensor for measuring muscle oxygen saturation during incremental cycling exercise. [1]
• The rise of sports analytics supports adoption because teams are using physiological data to guide training decisions.
• The market also benefits from rising use of body-worn performance devices as athletes add real-time physiological tools to training plans.
• Coaches use SmO2 patterns to refine warmups and recovery timing.

What are the defining numbers behind muscle oxygen sensors market growth?

USD 102.0 million absolute opportunity by 2036, led by the United States and the Netherlands.

• Demand Drivers in the Market
  • Athletes need local muscle feedback during pacing and interval training.
  • Coaches need recovery signals that go beyond heart rate.
  • Sports labs need field-based NIRS tools for testing outside controlled settings.
  • Rehabilitation teams need objective muscle response data during return-to-training programs.
• Key Segments Analyzed
  • By Product Type: Wearable NIRS Muscle Oxygen Sensors are expected to hold 41.0% share in 2026 because field use starts with portable SmO2 devices.
  • By Sport Type: Cycling leads because power, pacing and muscle oxygen trends can be compared during steady workloads. The share is projected at 34.0% in 2026.
  • By Customer Type: Endurance Athletes and Coaches lead because they actively use pacing and threshold data. This customer group is likely to account for 43.0% share in 2026.
  • By Delivery Model: Device-Plus-App Packages lead as users need both sensor hardware and interpretation. The model is projected to hold 38.0% share in 2026.
  • By End Use: Pacing and Threshold Training is expected to hold 37.0% share in 2026 because athletes first use SmO2 data to adjust intensity.
  • By Geography: The United States is projected to record 19.4% CAGR through 2036 as endurance coaching and sports science centers expand SmO2 use.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Muscle oxygen sensors are giving athletes a local view of effort. We see coaches asking how muscles respond before heart rate or power alone can explain fatigue. Providers that combine reliable NIRS hardware with simple training guidance will gain stronger access to endurance and sports science budgets.”
• Strategic Implications
  • Device brands should simplify SmO2 interpretation for non-scientist users.
  • Coaches should standardize placement before comparing athlete sessions.
  • Performance clinics can package SmO2 testing with threshold and recovery assessments.
  • Providers should support integrations with bike computers and training apps.

Endurance athletes are the first major user base. Moxy Monitor states that its device is a mobile, non-invasive way to measure SmO2 and is used by Olympic and world champion athletes. [2] This gives the category a performance-led base before wider fitness adoption.

The United States is projected to record 19.4% CAGR through 2036 as endurance coaching, sports science labs and high-performance centers expand SmO2 use. The Netherlands will gain from Artinis and Train.Red-linked muscle oxygen technology. The country is expected to post 18.2% CAGR through 2036. Australia is likely to record 17.5% CAGR as triathlon, cycling and rowing programs adopt oxygen monitoring. The United Kingdom is forecast to advance at 16.7% CAGR as performance clinics and endurance clubs test SmO2 training. Japan is set to record 15.9% CAGR as running communities and rehabilitation programs add wearable muscle monitoring.

How does the muscle oxygen sensors market break down by segment?

Wearable NIRS Muscle Oxygen Sensors lead at 41.0%; Cycling leads at 34.0%.

Which product type dominates?

Wearable NIRS Muscle Oxygen Sensors hold 41.0% share in 2026.

Wearable NIRS Muscle Oxygen Sensors are expected to hold 41.0% share in 2026 because athletes need field-ready tools that can be used during normal sessions. These sensors track SmO2 on targeted muscles and support training review after workouts. The product type leads because reliability and signal quality are central to athlete and clinic trust. Portable NIRS devices lead because lab-only tools cannot serve daily athlete use.

Which sport type dominates?

Cycling leads because power and muscle oxygen trends can be compared during controlled workloads.

Cycling leads because athletes can compare SmO2 against power output and heart rate during steady efforts. This makes pacing and threshold work easier to interpret. The sport type is projected to capture 34.0% share in 2026. Cycling adoption also supports training review because muscle oxygen trends help athletes test pacing, fueling and warm-up routines.

Which customer type dominates?

Endurance Athletes and Coaches lead because they actively use pacing and threshold data.

Endurance Athletes and Coaches lead because they are willing to test new physiological metrics when performance gains are measurable. SmO2 data helps them understand muscle desaturation, recovery and repeat-interval readiness. This customer group is likely to account for 43.0% share in 2026. Sensor adoption also benefits as small optical devices become easier to pair with training platforms.

Which delivery model dominates?

Device-Plus-App Packages lead because users need hardware and interpretation together.

Device-Plus-App Packages lead because raw SmO2 values can confuse users without guidance. Athletes need graphs, muscle-state cues and session summaries from the same system. The model is projected to hold 38.0% share in 2026. Train.Red states that its platform offers real-time muscle performance insights with up to 22 units at 10 Hz. [4]

Which end use dominates?

Pacing and Threshold Training holds 37.0% share in 2026.

Pacing and Threshold Training leads because athletes first use SmO2 data to adjust intensity during intervals and endurance sessions. Artinis states that PortaMon MKIII measures local tissue saturation index, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in muscle tissue. [3] The end use is expected to hold 37.0% share in 2026. This use case fits the shift toward tools that support measurable training routines.

What is accelerating muscle oxygen sensors demand, and what is holding it back?

Endurance performance use, wearable NIRS validation and coach-led testing drive demand; interpretation complexity restrains adoption.

Endurance performance use is the main driver. Athletes use SmO2 to understand muscle oxygen delivery and utilization during training. Coaches can compare warmup quality and repeat-interval recovery with session goals.

Wearable NIRS validation adds a second driver. NNOXX states that its platform gives real-time measurements of exercise effectiveness and efficiency inside working muscles. [5] This supports broader interest in local muscle response instead of whole-body metrics alone.

Coach-led testing also supports the market. Performance centers can use SmO2 sensors during cycling, rowing and running assessments. The data can support threshold work and recovery programming.

The main restraint is interpretation complexity. SmO2 readings vary by sensor placement, tissue thickness and muscle group. Users may over-read short-term changes if they lack a testing protocol. Providers must improve education and automated guidance before the market expands beyond trained athletes.

Where do the biggest muscle oxygen sensor opportunities sit?

Endurance coaching, sports science labs and rehabilitation testing.

• Endurance Coaching: Coaches can use SmO2 to refine pacing and warmup routines.
• Sports Science Labs: Labs can pair portable NIRS with field testing outside controlled environments.
• Rehabilitation Testing: Clinics can assess local muscle response during return-to-training programs.

Which countries are scaling muscle oxygen sensors fastest?

United States 19.4%, Netherlands 18.2%, Australia 17.5%, United Kingdom 16.7%, Japan 15.9%.

Based on regional analysis, the muscle oxygen sensors market is segmented into North America, Western Europe, Asia Pacific, Latin America, and Middle East and Africa.

What is powering the United States lead?

19.4% CAGR, driven by Moxy Monitor and endurance coaching programs.

The United States is projected to record 19.4% CAGR through 2036 as endurance coaching and sports science centers expand SmO2 use. The country has a large base of cyclists, triathletes and performance labs. Demand will focus on threshold testing and rehabilitation support. Device-plus-app models will gain as users need simpler interpretation. Growth will favor providers that connect sensors with bike computers and training platforms.

How is the Netherlands scaling muscle oxygen sensor demand?

18.2% CAGR, backed by Artinis and strong NIRS device expertise.

The Netherlands benefits from local NIRS device expertise and sports technology activity. Local strengths in research devices and athlete testing support adoption. The country is expected to post 18.2% CAGR through 2036 as cycling and speed skating programs increase SmO2 use. Demand will focus on field testing and sports science applications. Growth will favor companies that connect research-grade accuracy with easier athlete workflows.

What underpins Australia’s growth?

17.5% CAGR, supported by triathlon and high-performance sport institutes.

Australia is building demand through endurance sport culture and outdoor training programs. Coaches are likely to use SmO2 data during interval sessions and recovery testing. The country is likely to record 17.5% CAGR over the forecast period as triathlon and rowing programs adopt oxygen monitoring. Demand will favor rugged sensors that work in field conditions. Growth will also come from high-performance institutes and physiotherapy clinics.

What supports the United Kingdom outlook?

16.7% CAGR, driven by performance clinics and endurance club testing.

The United Kingdom is forecast to advance at 16.7% CAGR through 2036 as performance clinics and endurance clubs test SmO2 training. Athletes are using more data-led methods in running and cycling. Coaches need clearer local muscle feedback during threshold sessions. Clinics can add muscle oxygen testing to return-to-sport assessments. Growth will favor systems that simplify interpretation for amateur athletes.

How is Japan scaling muscle oxygen sensor adoption?

15.9% CAGR, backed by running communities and rehabilitation programs.

Japan is scaling adoption through compact performance devices and structured training tools. Sports labs can use SmO2 sensors for field testing and athlete education. The country is set to record 15.9% CAGR by 2036 as running communities and rehabilitation programs add wearable muscle monitoring. Rehabilitation use will gain as clinics seek local muscle response data. Growth will favor compact hardware and easy app workflows.

Who leads the muscle oxygen sensors market?

Moxy Monitor, Artinis and Train.Red lead through wearable SmO2 sensors, research-grade NIRS systems and app-led muscle oxygen training.

Muscle oxygen sensors are used by endurance athletes, coaches, sports labs and rehabilitation teams. Moxy Monitor provides a wearable SmO2 sensor used by athletes and researchers for daily training guidance. Artinis Medical Systems provides research-grade NIRS devices such as PortaMon for muscle oxygenation measurement. Train.Red offers muscle oxygen sensors and an app-led system for athletes and coaches.

NNOXX provides a wearable performance platform that measures working muscle response in real time. Moor Instruments supports muscle oxygen assessments using NIRS methods and tissue oxygenation equipment. [6] Competition through 2036 will depend on sensor accuracy, app clarity and coach education.

Providers that combine durable sensors with practical training cues will be better placed. Research-grade firms can win sports lab and rehabilitation work. App-led providers can win endurance athletes. Distribution partners can expand reach through coaching education and performance centers.

Which companies are the key players?

Moxy Monitor, Artinis Medical Systems, Train.Red, NNOXX, and Moor Instruments.

• Moxy Monitor
• Artinis Medical Systems
• Train.Red
• NNOXX
• Moor Instruments

Bibliography

• [1] Peikon, E., Corso, J. L., Otic, N., Kierul, O., Franceschini, M. A., & Robinson, M. (2025). Continuous monitoring of muscle oxygenation in endurance athletes during incremental cycling: Experimental validation of a wearable continuous-wave NIRS sensor using frequency-domain near-infrared spectroscopy. Bioengineering, 12(11), 1153.
• [2] Moxy Monitor. (2026). Muscle oxygen monitor. Moxy Monitor.
• [3] Artinis Medical Systems. (2026). PortaMon MKIII: Gold standard NIRS muscle oxygenation. Artinis Medical Systems.
• [4] Train.Red. (2026). Improve your muscle performance. Train.Red.
• [5] NNOXX. (2026). NNOXX wearable muscle oxygen platform. NNOXX.
• [6] Moor Instruments. (2026). Muscle oxygen assessments. Moor Instruments.

This Report Addresses

• Strategic intelligence on muscle oxygen sensors across product type, sport type and customer type.
• Segment analysis covering Wearable NIRS Muscle Oxygen Sensors, Cycling, Endurance Athletes and Coaches, Device-Plus-App Packages and Pacing Training.
• Regional outlook covering the United States, Netherlands, Australia, United Kingdom and Japan.
• Competitive analysis of Moxy Monitor, Artinis Medical Systems, Train.Red, NNOXX, and Moor Instrument.
• Product assessment covering wearable NIRS sensors, research-grade oximeters, app-connected SmO2 sensors and multi-site systems.
• Sport-type assessment covering cycling, running, triathlon, rowing and rehabilitation programs.
• Primary interviews, provider checks, official source review and muscle oxygen sensor validation support the forecast.

What does the muscle oxygen sensors market cover?

Wearable NIRS devices that measure muscle oxygen saturation during exercise and recovery.

The muscle oxygen sensors market covers wearable devices and platforms that monitor local muscle oxygenation using near-infrared spectroscopy. It includes SmO2 sensors, research-grade muscle oximeters, app-connected dashboards and multi-site monitoring systems. The category connects with wireless health and fitness devices because it depends on body-worn measurement and mobile data display.

The market differs from heart rate wearables because it measures local muscle response. Adoption also benefits from smart fitness behavior as active users become more comfortable with sensor-guided training.

What is included in the scope?

SmO2 sensors and sports science software.

The scope includes wearable NIRS sensors that measure muscle oxygen saturation on targeted muscles. It covers app dashboards and multi-sensor monitoring for lab or field use. Some platforms are also moving toward wearable AI interpretation as users seek easier training cues from raw oxygen data.

The scope includes single-sensor systems for endurance athletes and multi-site systems for research settings. It also covers integrations with wearable computing devices that combine SmO2 data with heart rate, power and motion signals.

What is excluded from the scope?

Pulse oximeters and clinical oxygen monitors without muscle-specific measurement.

The scope excludes fingertip pulse oximeters that measure blood oxygen saturation at the systemic level. It excludes medical oxygen monitors unless they measure local muscle tissue oxygenation. It excludes general fitness trackers with no SmO2 or NIRS function. It also excludes lactate testing devices unless muscle oxygen data is part of the platform.

How was the analysis built?

100+ sources, 40+ company portfolios, 25+ countries, 20+ interviews.

• Primary Research:
  • Primary research includes interviews with endurance coaches and sports science staff. It includes input from rehabilitation clinicians and high-performance training centers.
• Desk Research:
  • Desk research reviews NIRS validation work and official provider sources. It covers wearable SmO2 sensors and muscle oxygen training platforms.
• Market-Sizing and Forecasting:
  • Forecasting uses endurance athlete populations and device replacement cycles. Sensor pricing and coaching attachment support the market assessment.
• Data Validation and Update Cycle:
  • Forecasts are validated through provider checks and coach feedback. Product updates and sports science adoption patterns help confirm market direction.